We report the case of 52-year-old heart transplant recipient positive for Epstein-Barr virus (EBV) and CD3 polymorphic post-transplant lymphoproliferative disorder (PTLD). At age 39 years, the patient underwent heterotopic heart transplantation for end-stage ischemic dilated cardiomyopathy in a setting of irreversible pulmonary hypertension. He was asymptomatic for 13 years after transplantation. During the intervening period, he sustained an episode of rejection without apparent sequelae. Immunosuppression consisted of cyclosporine, azathioprine, and corticosteroids.
Post-transplantlymphoproliferative disorder in the heart late after heterotopic transplantation:autopsy findings
TURILLAZZI, EMANUELA;PENNELLA, ANTONIO;NERI, MARGHERITA;FINESCHI, VITTORIO
2010-01-01
Abstract
We report the case of 52-year-old heart transplant recipient positive for Epstein-Barr virus (EBV) and CD3 polymorphic post-transplant lymphoproliferative disorder (PTLD). At age 39 years, the patient underwent heterotopic heart transplantation for end-stage ischemic dilated cardiomyopathy in a setting of irreversible pulmonary hypertension. He was asymptomatic for 13 years after transplantation. During the intervening period, he sustained an episode of rejection without apparent sequelae. Immunosuppression consisted of cyclosporine, azathioprine, and corticosteroids.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
